Katherine M Liebman

Title: Katherine M Liebman: Innovator in Modified Chloroquine Compounds

Introduction

Katherine M Liebman is a notable inventor based in Portland, Oregon. She has made significant contributions to the field of pharmaceuticals, particularly in the development of modified chloroquine compounds. Her work focuses on addressing challenges posed by chloroquine-resistant malaria parasites.

Latest Patents

Katherine M Liebman holds one patent titled "Modified chloroquines with single ring moiety or fused ring moiety." This patent discloses modified chloroquine compounds that feature single ring or fused ring moieties. The patent also includes pharmaceutical compositions that comprise these compounds, methods for using them to inhibit or treat diseases caused by both chloroquine-resistant and chloroquine-sensitive malaria parasites, as well as other chloroquine-susceptible microorganisms. Additionally, it outlines processes and intermediates useful for preparing such compounds.

Career Highlights

Throughout her career, Katherine has worked with various organizations, including Designmedix, Inc. and Portland State University. Her innovative research has contributed to advancements in the treatment of malaria and other related diseases.

Collaborations

Katherine has collaborated with esteemed colleagues such as David H Peyton and Steven P Burgess, further enhancing her research and development efforts in the pharmaceutical field.

Conclusion

Katherine M Liebman's work in modified chloroquine compounds represents a significant advancement in the fight against malaria. Her innovative approach and dedication to research continue to impact the pharmaceutical industry positively.